Literature DB >> 11200684

Creutzfeldt-Jakob disease: heat shock protein 70 mRNA levels in mononuclear blood cells and clinical study.

W C Shyu1, M C Kao, W Y Chou, Y D Hsu, B W Soong.   

Abstract

Prion diseases such as Creutzfeldt-Jakob disease (CJD) are associated in most cases with the accumulation of an unusual isoform of prion protein (PrPSC). PrPSC is derived from the abnormal folding of the cellular isoform of prion protein (PrPC). On the other hand, heat shock protein is known to ensure proper protein assembly and folding and to facilitate proteolytic digestion of abnormal or denatured proteins. Many studies have therefore hypothesized that heat shock protein is linked to prion disease. We examined the relationship between heat shock protein HSP70 and prion disease in CJD patients. HSP70 mRNA levels in mononuclear blood cells (MBCs) were compared in 14 CJD patients (10 confirmed by histo-pathological study), 12 vascular dementia (VD) patients, 16 patients with Parkinson's disease and dementia (PD) and 14 nondemented control subjects. The possible correlation between HSP70 mRNA expression levels and clinical findings was also evaluated. HSP70 mRNA expression levels in MBCs were measured by northern blotting. HSP70 mRNA levels in MBCs from patients with CJD were significantly higher than those from patients with VD or PD and in nondemented controls. Age at symptom onset, dementia severity, disease duration and neuroimaging grade of CJD patients were not correlated with relative HSP70 mRNA levels. No significant relationship between HSP70 mRNA levels and ageing was found. These results suggest that measurement of HSP70 mRNA in MBCs might provide an auxiliary tool for the diagnosis of CJD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11200684     DOI: 10.1007/s004150070048

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Plasminogen: A cellular protein cofactor for PrPSc propagation.

Authors:  Charles E Mays; Chongsuk Ryou
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

Review 2.  Potential roles for prions and protein-only inheritance in cancer.

Authors:  H Antony; A P Wiegmans; M Q Wei; Y O Chernoff; K K Khanna; A L Munn
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).

Authors:  Charles E Mays; Enrique Armijo; Rodrigo Morales; Carlos Kramm; Andrea Flores; Anjana Tiwari; Jifeng Bian; Glenn C Telling; Tej K Pandita; Clayton R Hunt; Claudio Soto
Journal:  J Biol Chem       Date:  2019-07-18       Impact factor: 5.157

Review 4.  The chaperone Grp78 in protein folding disorders of the nervous system.

Authors:  Julie A Moreno; Evelyn Tiffany-Castiglioni
Journal:  Neurochem Res       Date:  2014-08-09       Impact factor: 3.996

5.  Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit.

Authors:  Unekwu M Yakubu; Celso S G Catumbela; Rodrigo Morales; Kevin A Morano
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

6.  In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms.

Authors:  Pedro Fernandez-Funez; Sergio Casas-Tinto; Yan Zhang; Melisa Gómez-Velazquez; Marco A Morales-Garza; Ana C Cepeda-Nieto; Joaquín Castilla; Claudio Soto; Diego E Rincon-Limas
Journal:  PLoS Genet       Date:  2009-06-05       Impact factor: 5.917

7.  Combined pharmacological induction of Hsp70 suppresses prion protein neurotoxicity in Drosophila.

Authors:  Yan Zhang; Sergio Casas-Tinto; Diego E Rincon-Limas; Pedro Fernandez-Funez
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

8.  Membrane-enriched proteome changes and prion protein expression during neural differentiation and in neuroblastoma cells.

Authors:  J A Macedo; D Schrama; I Duarte; E Tavares; J Renaut; M E Futschik; P M Rodrigues; E P Melo
Journal:  BMC Genomics       Date:  2017-04-22       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.